celecoxib has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Bary, NA | 1 |
| Hashem, T | 1 |
| Metwally, H | 1 |
| Ghany, AA | 1 |
| El Mageed, HA | 1 |
| Buckstein, R | 1 |
| Kerbel, RS | 1 |
| Shaked, Y | 1 |
| Nayar, R | 1 |
| Foden, C | 1 |
| Turner, R | 1 |
| Lee, CR | 1 |
| Taylor, D | 1 |
| Zhang, L | 1 |
| Man, S | 1 |
| Baruchel, S | 1 |
| Stempak, D | 1 |
| Bertolini, F | 1 |
| Crump, M | 1 |
| Wang, W | 1 |
| Kardosh, A | 1 |
| Su, YS | 1 |
| Schonthal, AH | 1 |
| Chen, TC | 1 |
2 trials available for celecoxib and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
A phase II study of high-dose celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclophospha | 2010 |
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Celecoxib; Cyclophosphamide; Disease Progressi | 2006 |
1 other study available for celecoxib and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo model.
Topics: Animal Feed; Animals; Apoptosis; Burkitt Lymphoma; Celecoxib; Cell Line, Tumor; Central Nervous Syst | 2006 |